Compare Raytheon Technologies Corp (RTX) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Raytheon Technologies Corp vs 22nd Century Group Inc — how do they compare? Raytheon Technologies Corp trades at $198.22 (market cap $266.25B), while 22nd Century Group Inc trades at $2.17 (market cap $1.50M). The key difference: Raytheon Technologies Corp is far larger — about 177500× 22nd Century Group Inc's market cap, and Raytheon Technologies Corp pays a 1.48% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| RTX | XXII | |
|---|---|---|
Market Cap | $266.25B | $1.50M |
Sector | Industrials | Technology |
52-Week High | $225.49 | $594.00 |
52-Week Low | $155.00 | $2.13 |
Enterprise Value | $296.80B | -$2.81M |
Dividend Yield | 1.48% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RTX trades at $197.55, down 1.61% today, but maintains a bullish technical outlook with strong support near $197 and resistance at $200. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.75. Revenue growth accelerated to $88.6 billion in 2025, with net income reaching $6.73 billion. Recent contract wins include a $515 million U.S. Navy radar award announced June 3, 2026.
Outlook remains positive with 65% analyst buy ratings and a $235.33 price target implying 19% upside. Key risks include execution challenges in scaling munitions production and dependence on defense budgets. Strong cash flow generation and expanding margins support continued dividend payments, with the next $0.73 dividend payable September 3, 2026.
XXII trades at $2.29, down 4.58% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a Q2 2026 EPS miss of -15.6 versus -6 expected, with negative gross and net income margins. Recent news highlights VLN brand expansion and a 20:1 reverse stock split effective June 12, 2026.
Outlook is challenged by persistent losses and high cash burn, though analyst consensus is 75% buy. Key risks include execution on commercialization and profitability turnaround. The stock's low valuation multiples may attract speculative interest if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
